...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Annual Financial Reporting
4
Mar 22, 2024 12:55PM
1
Mar 22, 2024 03:10PM
2
Mar 22, 2024 03:46PM
1
Mar 22, 2024 04:17PM
1
Mar 22, 2024 04:57PM
1
Mar 22, 2024 05:43PM
2
Mar 23, 2024 10:17AM
1
Mar 23, 2024 06:16PM
1
Mar 23, 2024 07:48PM

I really don't know what your going on about fuzzy. All I did is answer your question. The debenture is what it is. We can't change that. If HL decides to convert to common shares not much anyone can do about it unless the company pays off the $6M loan.

if you think Zenith can save the day, so be it. No problem. 

Koo

1
Mar 23, 2024 08:21PM
Share
New Message
Please login to post a reply